EXCLUSIVE AGREEMENTExclusive Agreement • May 1st, 2007 • Telomolecular Corp • Services-commercial physical & biological research • California
This Agreement between THE BOARD OF TRUSTEES OF TITIE LELAND STANFORD JUNIOR UNIVERSITY ("Stanford"), an institution of higher education having powers tinder the laws of the State of California, and Telomolecular, Inc. ("Telomolecular"), a corporation having a principal lace of business at 8037 Orange Avenue, Fair Oaks. ('A 95628, is effective on the 3rs day of March, 2006 ("Effective Date").
LEASE AGREEMENTLease Agreement • May 1st, 2007 • Telomolecular Corp • Services-commercial physical & biological research • California
This Lease (the "Lease"), dated for reference purposes as of the 30th day of June 2006, between TETON I, a California Limited Partnership, hereinafter called Landlord, and MATTHEW A. SARAD, dba TELOMOLECULAR CORPORATION, hereinafter called Tenant.
ContractTechnology Transfer Agreement • May 1st, 2007 • Telomolecular Corp • Services-commercial physical & biological research • California
This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY ("Stanford11), an institution of higher education having powers under the laws of the State of California, and Telomolecular, Inc. ("Telomolecular"), a corporation having a principal place of business at 8037 Orange Avenue, Fair Oaks. CA 95628, is effective on the("Effective Date"). 1 BACKGROUND Stanford has an assignment of an invention a target and associated compounds useful for regenerative medicine. It is entitled "Notch-Mediated Tissue and Organ Repair through Control of Endogenous Stem and Progenitor Cell Behavior," was invented in the laboratory of Dr, Thomas Rando, an employee of Stanford and the United States Department of Veterans Affairs ("VA"), and is described in Stanford Docket 02-231. The invention was made in the course of research supported by the NIH. Stanford wants to have the invention perfected and marketed as soon as possible so that resulting products may be available for
JAN-1-2002 12:03P FROM: UNIVERS1TY OF Nebraska Medical Center SPONSORED PROGRAMS ADMINISTRATION NEBRASKA'S HEALI H SCIENCE CENTER Via Federal Express April 26, 2006 Matthew Sarad CEO, Telomolecular Cor. 8037 Orange Ave. Fair Oaks, CA 95628 Re:...Agreement Between Telomolecular and the University of Nebraska Medical Center • January 16th, 2007 • Telomolecular Corp • Services-commercial physical & biological research • Nebraska
On behalf of Dr. Vinod Labhasetwar at the University of Nebraska Medical Center, enclosed are two (2) Agreements for the above referenced project. Please have the appropriate institutional signatory review and sign the Agreements and return one (1) fully executed Agreement to me at the Sponsored Programs Administration office at the address listed below.
ContractExclusive Agreement • May 1st, 2007 • Telomolecular Corp • Services-commercial physical & biological research • California
STANFORD UNIVERSITY * OFFICE OF TECHNOLOGY LICENSING 1705 EL CAMINO REAL * PALO ALTO, CA 94306-1106 (650! 723-0651 * FAX (650) 725-7295 Ally 18,2006 Matt Sarad CEO Telmolecular, Inc. 8037 Orange Ave. Fair Oaks, CA 95628 Re: Signature copies, Cases S97-099 and S02-231 Dear Matt: Enclosed are two sets of two agreements for the Notch 1 and the Mitofusins technologies. Please sign and return one copy of each agreement to my attention. Gregg W. TCyl Licensing Associate Sincerely, http://otl.stanford.edu EXCLUSIVE AGREEMENT This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY ("Stanford"), an institution of higher education having powers under the laws of the State of California, and Telomoleeular, Inc. ("Telomolecular"), a corporation having a principal place of business at 8037 Orange Avenue, Fair Oaks, CA 95628, is effective on the 17 day July 2007 ("Effective Date"). 1 BACKGROUND Stanford has an assignment of an invention that p
